Avance Biosciences has inaugurated its new Potency and Cell-Based Assay Center of Excellence in Houston, a facility designed to enhance the company’s capabilities in potency and functional cell-based assays under GMP compliance. This center aims to support a diverse range of clients involved in the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies. Equipped with advanced instrumentation and led by a team of experienced cell biologists and assay development specialists, the center is positioned to provide tailored services that meet the specific needs of its clientele.
The establishment of this center underscores Avance’s commitment to delivering precise and scientifically robust potency data. According to CEO Xuening (James) Huang, the center will enable the company to provide complex custom assays more efficiently, reflecting a strategic investment in analytical and bioanalytical solutions for next-generation therapeutics. With a focus on diverse modalities such as lipid nanoparticles, monoclonal antibodies, and engineered cell therapies, the center is set to centralize operations, thereby improving turnaround times and standardizing workflows for its growing client base.
Start your 7-day trial and see what the database can do →
